2026 Ugo Pastorino: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	92	11212	10537	410	392	576	34758

Overview

Ugo Pastorino is affiliated with the University of Milan in Italy and specializes primarily in the field of Medicine, with a strong focus on pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, and oncology. Their research encompasses a variety of subfields including molecular biology and cancer research.

Their scientific work covers several main topics, notably:

Lung Cancer Diagnosis and Treatment
Radiomics and Machine Learning in Medical Imaging
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Neuroendocrine Tumor Research Advances
MicroRNA in disease regulation
Medical Imaging Techniques and Applications

Ugo Pastorino has contributed to numerous peer-reviewed articles with recent papers including:

"IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy" (2020), published in the Journal of Thoracic Oncology
"Progress in cancer mortality, incidence, and survival: a global overview" (2020), published in European Journal of Cancer Prevention
"Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy" (2020), published in Tumori Journal
"Lung Screening Benefits and Challenges: A Review of The Data and Outline for Implementation" (2020), published in Journal of Thoracic Oncology
"Baseline computed tomography screening and blood microRNA predict lung cancer risk and define adequate intervals in the BioMILD trial" (2022), published in Annals of Oncology

Their publishing activity is frequently seen in journals such as:

Journal of Thoracic Oncology
Tumori Journal
bioRxiv (Cold Spring Harbor Laboratory)
Cancer Research
Translational Lung Cancer Research

Throughout their career, Ugo Pastorino has collaborated extensively with several researchers. Frequent co-authors include Federica Sabia, Gabriella Sozzi, Luigi Rolli, Alfonso Marchianò, and Roberta Eufrasia Ledda.

Best Publications

Comprehensive genomic profiles of small cell lung cancer

Julie George;Jing Shan Lim;Se Jin Jang;Yupeng Cun

2106
Citations
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases.

Ugo Pastorino;Marc Buyse;Godehard Friedel;Robert J. Ginsberg

1376
Citations
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.

Giulia Bertolini;Luca Roz;Paola Perego;Monica Tortoreto

1001
Citations
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

Mattia Boeri;Carla Verri;Davide Conte;Luca Roz

809
Citations
The FHIT Gene at 3p14.2 Is Abnormal in Lung Cancer

Gabriella Sozzi;Maria Luisa Veronese;Massimo Negrini;Raffaele Baffa

790
Citations
Computed tomography screening and lung cancer outcomes.

Peter B. Bach;James R. Jett;Ugo Pastorino;Melvyn S. Tockman

722
Citations
Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer

Gabriella Sozzi;Davide Conte;MariaElena Leon;Rosalia Cirincione

720
Citations
Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.

Ugo Pastorino;Massimo Bellomi;Claudio Landoni;Elvio De Fiori

596
Citations
European position statement on lung cancer screening

Matthijs Oudkerk;Anand Devaraj;Rozemarijn Vliegenthart;Thomas Henzler

561
Citations
Effect of lung-volume-reduction surgery in patients with severe emphysema.

Duncan Geddes;Michael Davies;Hiroshi Koyama;David Hansell

502
Citations
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.

Ugo Pastorino;Marta Rossi;Valentina Rosato;Alfonso Marchianò

495
Citations
EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer

Nico van Zandwijk;Otilia Dalesio;Ugo Pastorino;Nico de Vries

483
Citations
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U. Pastorino;M. Silva;S. Sestini;F. Sabia

452
Citations
Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study

Gabriella Sozzi;Mattia Boeri;Marta Rossi;Carla Verri

448
Citations
Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis

Francesco Pezzella;Ugo Pastorino;Elda Tagliabue;Salvatore Andreola

434
Citations
Adjuvant treatment of stage I lung cancer with high-dose vitamin A.

U Pastorino;M Infante;M Maioli;G Chiesa

434
Citations
Loss of FHIT Function in Lung Cancer and Preinvasive Bronchial Lesions

Gabriella Sozzi;Ugo Pastorino;Luisa Moiraghi;Elda Tagliabue

427
Citations
EML4-ALK Rearrangement in Non-Small Cell Lung Cancer and Non-Tumor Lung Tissues

Maria Paola Martelli;Gabriella Sozzi;Luis Hernandez;Valentina Pettirossi

414
Citations
Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group study of 255 patients

Albert N. van Geel;Ugo Pastorino;Karl W. Jauch;Ian R. Judson

398
Citations
Immunocytochemical markers in stage I lung cancer: relevance to prognosis.

Ugo Pastorino;Salvatore Andreola;Elda Tagliabue;Francesco Pezzella

397
Citations

Frequent Co-Authors

Gabriella Sozzi University of Milan

Giuseppe Pelosi University of Milan

Silvana Pilotti University of Milan

Marina Chiara Garassino University of Chicago

Peter Goldstraw Imperial College London

Carlo La Vecchia University of Milan

Filippo de Braud University of Milan

Marco A. Pierotti University of Bari Aldo Moro

Elda Tagliabue Fondazione IRCCS Istituto Nazionale dei Tumori

Alessandro Gronchi University of Milan

External Links

Personal website of Ugo Pastorino

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

If you’re considering a career in healthcare but not ready to commit to the rigorous path of becoming a doctor, there are excellent alternative pathways to explore. For example, many students start in nursing for its versatility and demand. Some choose to apply to easy nursing schools to get into to begin their journey more quickly and build clinical experience.

Other healthcare careers, such as medical billing and coding, offer flexibility and the potential to work remotely. Enrolling at accredited medical billing and coding schools with financial aid can help make this pathway affordable and accessible.

Additionally, prospective nursing students who are concerned about entrance exams might look for nursing schools that don't require teas test. This can simplify the application process and open up more opportunities.

For those interested in healthcare leadership, earning a degree from one of the health administration degree programs online is a fast-track to roles in management and operations.